Biotrofix, Inc. is a premier preclinical CRO specializing in models of CNS and vascular diseases. The Company was founded by Drs. Seth Finklestein and JingMei Ren, who have over 25 and 10 years of experience, respectively, in this field, in both academic and industrial settings.

Biotrofix is located in well-equipped laboratories, with an AAALAC-accredited animal facility. The Company performs its services on a strictly fee-for-service basis, and takes no intellectual property rights on the work it does for clients. A comprehensive report is submitted to clients at the end of each study. Biotrofix currently provides contract services for several leading biotech and global pharmaceutical companies.